Last updated on November 2017

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Adaptive Design Study Evaluating the Analgesic Efficacy and Safety of Intravenous CR845 in Patients Undergoing Abdominal Surgery. Clinical trial NCT02542384, CR845-CLIN3001.


Brief description of study

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Adaptive Design Study Evaluating the Analgesic Efficacy and Safety of Intravenous CR845 in Patients Undergoing Abdominal Surgery. Clinical trial NCT02542384, CR845-CLIN3001.

Detailed Study Description

The study schedule is comprised of a 14-day screening period, a treatment period and an observation period. All eligible subjects will be randomized into one of 4 treatment groups (1 of 3 dose levels or matched placebo). Study drug CR845 will be administered intravenously prior to surgery, and at specific time intervals after surgery. Additional rescue pain and anti-nausea medication will be made available. Post surgical changes in pain intensity, nausea and vomiting will be assessed.

Clinical Study Identifier: TX5650

Contact Investigators or Research Sites near you

Start Over

Cheryl Zinar, RN, BSN

Urologic Consultants of Southeastern Pennsylvania
Bala Cynwyd, PA USA

Recruitment Status: Closed


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.